Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
CM.7.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CM.7.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.5.3.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-15159.2France
BA.5.3.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.3.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.3.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BQ.1.22ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BQ.1.22ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.22ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.22NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BF.7.19ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BF.7.19ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BF.7.19ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.7.19NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FA.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FA.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FA.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FA.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
EE.4ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
EE.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EE.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EE.4NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-18639.2US
BQ.1.1.72ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BQ.1.1.72ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.1.72ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.1.72NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBJ.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBJ.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBJ.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBJ.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BF.14ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BF.14ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BF.14ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.14NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
CK.2.1.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
CK.2.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CK.2.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CK.2.1.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AY.86 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.86 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.86 (Delta)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AY.4.7 (Delta)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AY.4.7 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.4.7 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.4.7 (Delta)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AY.4.12 (Delta)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AY.4.12 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.4.12 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.4.12 (Delta)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AY.7.2 (Delta)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used